The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 370.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.405%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Results

26 Apr 2016 07:00

RNS Number : 2794W
Focusrite PLC
26 April 2016
 

Strictly embargoed until 07:00: 26 April 2016

 

Focusrite Plc ('Focusrite' or 'the Group')

 

Half Year Results for the period ended 29 February 2016

 

 

Focusrite Plc, the global music and audio products company supplying hardware and software products used by professional and amateur musicians, announces its half year results for the six months ended 29 February 2016.

 

Financial Highlights for the Six Months ended 29 February 2016

· Group revenue up by 8.7% to £25.9 million (HY15: £23.8 million)

· Adjusted EBITDA1 up by 3.1% to £4.8 million (HY15: £4.7 million)

· Operating profit up by 6.7% to £3.2 million (HY15: £3.0 million)

· Profit before tax £2.4 million (HY15: £3.5 million), down due to change in fair value of foreign exchange contracts at each balance sheet date

· Basic earnings per share 4.0p (HY15: 5.5p)

· Adjusted diluted earnings2 per share 4.6p (HY15: 6.0p)

· Net cash of £4.0 million (HY15: £4.7 million)

· Interim dividend of 0.65p recommended, up from 0.6p in HY15.

 

Operational Highlights

 

· Continued growth in all geographical territories

 

- USA by 7.0%, Europe, Middle East and Africa by 3.5% and Rest of World by 29.6%

 

· Launch of two important product lines

- Focusrite's Red Range (March 2016)

- Novation's Circuit (September 2015)

· Cumulative downloads of Launchpad App now up to 4.3 million (HY15: 2.8 million)

· Launch of eCommerce webstore in UK and Blocs Wave app

· Rated, for fifth consecutive year, as one of the 'Best 100 Small Companies To Work For' by The Sunday Times

· Awarded prestigious Queen's Award for Enterprise in the category of international trade.

 

Philip Dudderidge, Executive Chairman, commented:

 

"Once again, we have continued to grow in both of our main brands and across all regions. This growth is fuelled by our creation of the best quality products at each price point, our high performing people and our entrepreneurial culture. We believe our product and geographical diversification and significant addressable market give room for further growth in the future."

 

Commenting on current trading and outlook, Dave Froker, CEO said:

 

"Since the half year end, March and April have been busy, productive months and revenue has continued to grow in line with expectations. The new Focusrite Red product range has started shipping, existing products continue to sell well and we are excited about further significant new products due for release in the second half of the financial year."

 

1 Comprising of earnings adjusted for interest, taxation, depreciation, amortisation and non-underlying items.

2 Adjusted for non-underlying items comprising £0.7 million IPO costs in HY15 and £0.5 million legal costs in HY16.

 

Dividend timetable

The timetable for the interim dividend is as follows:

 

26 April 2016

Board to approve the recommended interim dividend

5 May 2016

Ex-dividend Date

6 May 2016

Record Date

3 June 2016

Dividend payment date

 

 

Enquiries:

 

Focusrite Plc:

+44 1494 836301

Phil Dudderidge (Chairman)

Dave Froker (CEO)

 

 

Jeremy Wilson (CFO)

 

 

 

Panmure Gordon

+44 20 7886 2500

Freddy Crossley / Alina Vaskina

 

Tom Salvesen

 

 

 

Belvedere Communications

+44 20 3567 0510 

John West

 

Kim Van Beeck

 

 

 

Notes to Editors

 

Focusrite is a global music and audio products group supplying hardware and software products used by professional and amateur musicians, which enables the high quality production of music.

 

The Group has two established and growing brands: Focusrite and Novation. The Focusrite brand makes audio interface and other products for audio recording musicians. The Novation brand allows its customers to make electronic music using synthesisers and computer-enabled technology.

 

The Group has a global customer base with a distribution network covering approximately 160 territories. Focusrite is headquartered in High Wycombe, United Kingdom with a marketing subsidiary in Los Angeles, United States and has around 160 employees.

Business and Operating Review

 

Overview

Focusrite is pleased to report continued positive momentum for the six months ending 29 February 2016 with turnover and profit growing in line with expectations.

Total revenues accelerated during the reported period and overall grew to £25.9 million, an increase of 8.7% over the same period in the previous year. Operating profits also grew, with adjusted EBITDA up by 3.1% to £4.8 million over the corresponding period. This growth was driven by new product releases which were supported by positive industry and consumer acceptance. The Group continues to penetrate new market segments and price-points.

Existing products continue to gain market share across our key geographies. In this regard, we were particularly pleased with the strong reported growth in Asia, emphasising the significant opportunity open to us to continue to grow our market share.

We are proud to report that for the fifth year, Focusrite was named as one of the '100 Best Small Companies to Work For' in the UK (Source: Sunday Times) and on 21 April 2016 (after the reported period ended) we were again awarded the prestigious Queen's Award for Enterprise in International Trade.

 

Operating Review

The management team is committed to pursuing its stated goals of innovation; disruption; making music easier to make; and expanding our addressable market.

 

Segmental analysis - markets

 

 

6 months to29 February 2016 (unaudited)

6 months to28 February 2015 (unaudited)

Year to31 August 2015 (audited)

£'000

£'000

£'000

Continuing operations

 

 

 

 

USA

 

9,069

8,476

18,498

Europe, Middle East and Africa

 

12,064

11,659

21,460

Rest of World

 

4,747

3,663

8,071

Consolidated revenue

 

25,880

23,798

48,029

 

Regionally, the USA grew by 7.0% despite the region being affected by the slower than expected take-up of the new products, Clarett and LaunchPad Pro, early in the period. Since then consumer demand has improved and they have continued to gain market share at a good rate. The growth was also impacted by the intentional wind-down of sales of some existing products prior to their replacement in the second half.

Europe, Middle East and Africa grew by 3.5%. This was despite the weakening of the Euro from an average of €1.30 in H1 FY15 to €1.37 in H1 FY16. The new distributors announced at the year end are settling in well and delivering growth.

Finally, the Rest of World region grew by 29.6%, particularly in Asia where our Novation products, in particular, have proved very popular.

Segmental analysis - products

 

6 months to29 February 2016

6 months to28 February 2015

Year to31 August 2015

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Revenue from external customers

 

 

 

Focusrite

16,946

15,330

31,187

Novation

7,287

6,831

14,169

Distribution

1,647

1,637

2,673

Total

25,880

23,798

48,029

 

Existing products continue to perform well across the board and, in particular, the Scarlett range of interfaces remains the number one selling product in its market segment globally. Pleasingly, it continues to gain share, even four years since it was first introduced.

However, to continue to progress, we need to keep innovating and product development remains our engine for growth. We have already launched a number of new products in the first half of the year including further products in the Clarett range and are firmly on track to deliver our targeted double digit number of new products by the year end.

Alongside engineering, innovation is paramount to success and we continue to spend between 6% and 7% of revenue on research and development so as to provide a constant stream of new and relevant products for our various channels.

All new products released to date have been delivered on or ahead of schedule and are gaining market share. The feedback via our sales channels and end customers has been positive with Clarett in particular being particularly well received.

We continue to strive to make music easier to make and in this regard we are particularly pleased with the launch of Circuit, the innovative grid-based groove box, first shipped in September 2015, with feedback indicating high end-user satisfaction.

Circuit, from Novation, is essentially a synthesiser, grid and sequencer combination. It is designed to inspire and gets users making electronic music in minutes. It is a great example of how we are encouraging musicians to 'start something', the hardest part of song writing. We expect this product to expand our addressable market of potential musicians.

On the Focusrite side of the business, we are opening up new market segments with our RedNet product expansion. RedNet products enable numerous high-quality audio signals to be distributed via 'Audio over IP' based technology, utilising common off the shelf networking infrastructure, in real time across a network and are targeted at the live sound and broadcast business-to-business markets. Clients include academic institutions, live concert venues, outside broadcasters, broadcast and recording studios and places of worship. We continue to invest in sales and marketing to support this new market segment and early indications are positive. This is particularly pleasing given the higher price point and margins associated with this range.

Also within Focusrite, we recently announced the launch of a new high-end interface range, the Red Series. This range was announced in March 2016, with the first of the range, the Red 4Pre, shipping in April and we expect the revenue benefit to begin to be seen later in the year. The range offers unequalled sound quality, speed and ease of use for professional recording engineers and producers, and has been widely acclaimed in the trade media. With multiple connectivity options the Red Series offers unprecedented versatility in any professional recording environment.

So what about disruption? Our latest initiative is very exciting in this regard. We have recently announced the launch of Blocs Wave, the second iOS app from our London software team. It has just started selling with strong support from Apple and it makes it easier for musicians to create their own sounds and songs from scratch on any iOS smartphone or tablet.

The app has been designed for everybody to use, whether a professional or beginner, and is highly intuitive. We are excited about its prospects.

 

Distribution and logistics initiatives

In March 2016, we launched Focusrite's first webstore in the UK, to sell the iTrack line of iOS recording devices, as well as refurbished products direct to end-users. It is early days, but we will watch the progress of this new channel with interest.

On the logistics chain side we are transitioning our business to Kuehne + Nagel to achieve more highly integrated supply chain and delivery management. This is expected to positively impact our logistics and further improve the efficiency of our operations.

In addition, we are continuously fine-tuning our distributor channels, upgrading and introducing new partners where necessary to ensure continued growth.

 

Financial Review

 

Revenue and profit

Driven principally by new launches and underpinned by strong sales of existing products, total Group revenues rose to £25.9 million, up 8.7% on the previous year.

Pleasingly, we maintained a similar gross margin as the previous year at around 39.8% (HY15: 39.4%). The growth in EBITDA was affected by foreign exchange (explained further below under 'Currency impact') and increased administrative expenses, particularly marketing campaign costs in support of the larger number of new product releases. Overall, adjusted EBITDA for the period was £4.8 million, an increase of 3.1%.

The Group has also provided for a non-recurring exceptional cost of £537,000 on legal cases relating to intellectual property and distribution contracts, which have no significant effect on our ongoing business and which have previously been disclosed as contingent liabilities in the Annual Report. The legacy intellectual property issues have now been resolved. The company is vigorously defending its position with one remaining ongoing distributor claim and continues to seek appropriate counsel.

Net financing costs were higher as we incurred a £0.7 million charge relating to the fair value of certain FX hedging instruments and the recognition of the corresponding FX hedging liability carried forward. This will be replaced by realised gains or losses as the hedging instruments are settled in the second half. Last year the equivalent was a gain of £0.5 million, which reversed as the FX hedging contracts were settled in the second half.

Overall this resulted in a reported profit before tax of £2.4 million versus £3.5 million in the prior year.

Our tax charge continued to benefit from research and development tax credits, resulting in an effective tax rate of approximately 12%.

Currency impact

 

6 months to29 February 2016

6 months to28 February 2015

Year to31 August 2015

Exchange rates

 

 

 

Average $:£

1.50

1.58

1.56

Average €:£

1.37

1.30

1.35

 

 

 

 

Period end $:£

1.43

1.50

1.54

Period end €:£

1.29

1.38

1.37

 

While the reported revenue growth was 8.7%, the revenue growth at constant exchange rates was 5.6%.

The primary reason for this was that the US Dollar strengthened from an average rate of $1.58:£1 (in HY15) to $1.50:£1 in this period. Approximately half of the Group's revenue and nearly all of the cost of sales are denominated in US Dollars, so this strengthening increased the revenue but had little effect on the gross profit.

For the Euro, approximately 27% of our revenue and very few costs are denominated in Euro, so any movement in that currency has a greater financial impact on profit. The Group converts the Euro revenue into its functional currency, Sterling, and enters into forward contracts (typically covering 75% of the forecast income) to mitigate against currency movements. In the first half of FY15, the average exchange rate was €1.30:£1 with hedging protection for the majority of the Euro cash flows at €1.23: £1. In effect, the weighted average Euro rate was approximately €1.25:£1. In the current period the average exchange rate was €1.37:£1 with hedging contracted for the majority of the Euro cash flows at an average of €1.35:£1. In effect, the weighted average Euro rate was approximately €1.35:£1.

Therefore, while the US Dollar strengthened by 5%, the weighted Euro rate weakened by 7% thereby limiting the total positive currency impact of the US Dollar on revenue and acting as a drag on profit growth.

 

Balance sheet

Inventories increased to £10.7 million (HY15: £7.8 million). This is partially attributable to the higher sales but mostly to higher stocks of recently introduced products to meet anticipated demand and five to six month lead times. We are already seeing sales increasing and so would expect stock levels of these new products to fall.

Debtors also increased to £9.8 million (HY15: £6.5 million). Again this was due to higher revenues, coupled with the impact of introducing new, longer credit terms for our major US distributor to help support new product distribution.

Creditors and accruals correspondingly rose to £8.7 million (HY15: £7.5 million). These are mainly an increase in trade creditors due to a higher purchase of stock. We have not experienced any significant changes in our creditor terms.

Cash flow

Cash at the period end stood at £4.0 million (HY15: £4.7 million). The negative cash flow was due largely to increases in stock and debtors. In particular, the major part of the increase in debtors was due to an increase in credit terms for the Group's US distributor. The Group remains cash generative over the medium-term and has significant credit headroom in place due to the committed five-year £10 million revolving credit facility ('RCF') with HSBC, which was completed during the period.

Dividends

The Group has a progressive dividend policy in place and the Board has approved an interim dividend of 0.65p, up 8.3% on prior year.

 

Outlook

Since the half year end, March and April have been busy, productive months and revenue has continued to grow in line with expectations. The new Focusrite Red product range has started shipping, existing products continue to sell well and we are excited about further significant new products due for release in the second half of the financial year.

 

 

 

 

Dave Froker Jeremy Wilson

Chief Executive Officer Chief Financial Officer

 

Condensed Consolidated Income Statement

For the six months ended 29 February 2016

 

Note

 

6 months to 29 February 2016

 

6 months to28 February 2015

 

Year to31 August 2015

 

 

 

(unaudited)

 

(unaudited)

 

(audited)

 

 

 

£'000

 

£'000

 

£'000

Revenue

 

 

25,880

 

23,798

 

48,029

Cost of sales

 

 

(15,575)

 

(14,429)

 

(29,381)

Gross profit

 

 

10,305

 

9,369

 

18,648

Administrative expenses

 

 

(7,150)

 

(6,411)

 

(12,328)

Adjusted EBITDA (non GAAP measure)

 

 

4,821

 

4,677

 

9,302

Depreciation and amortisation

 

 

(1,129)

 

(1,015)

 

(2,278)

Adjusted operating profit

 

 

3,692

 

3,662

 

7,024

Non-underlying items

 

 

(537)

 

(704)

 

(704)

Operating profit

 

 

3,155

 

2,958

 

6,320

Finance income

 

 

2

 

528

 

164

Finance costs

 

 

(725)

 

-

 

-

Profit before tax

 

 

2,432

 

3,486

 

6,484

Income tax expense

4

 

(292)

 

(622)

 

(1,022)

Profit for the period from continuing operations

 

2,140

 

2,864

 

5,462

 

 

 

 

 

 

 

 

Earnings per share

 

 

 

 

 

 

 

From continuing operations

 

 

 

 

 

 

 

Basic (pence per share)

7

 

4.0

 

5.5

 

10.4

Diluted (pence per share)

7

 

3.7

 

4.8

 

9.3

 

Condensed Consolidated Statement of Other Comprehensive Income

For the six months ended 29 February 2016

 

 

 

 

6 months to 29 February 2016

 

6 months to28 February 2015

 

Year to31 August 2015

 

 

 

(unaudited)

 

(unaudited)

 

(audited)

 

 

 

£'000

 

£'000

 

£'000

Profit for the period

 

 

2,140

 

2,864

 

5,462

Exchange differences on translation of foreign operations

 

 

38

 

-

 

-

Total comprehensive income for the period

 

 

2,178

 

2,864

 

5,462

Profit attributable to:

 

 

 

 

 

 

 

Equity holders of the Company

 

 

2,178

 

2,864

 

5,462

 

 

 

2,178

 

2,864

 

5,462

 

Condensed Consolidated Statement of Financial Position

As at 29 February 2016

 

Note

 

29 February 2016

 

28 February 2015

 

31 August 2015

 

 

 

(unaudited)

 

(unaudited)

 

(audited)

 

 

 

£'000

 

£'000

 

£'000

Assets

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

Goodwill

 

 

419

 

419

 

419

Other intangible assets

 

 

4,006

 

3,172

 

3,522

Property, plant and equipment

 

 

1,416

 

1,170

 

1,323

Deferred tax asset

 

 

-

 

34

 

-

Total non-current assets

3

 

5,841

 

4,795

 

5,264

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Inventories

 

 

10,732

 

7,839

 

8,633

Trade and other receivables

 

 

9,809

 

6,496

 

7,737

Other investments including derivatives

8

 

-

 

585

 

223

Cash and cash equivalents

8

 

3,952

 

4,725

 

6,173

Total current assets

 

 

24,493

 

19,645

 

22,766

Total assets

 

 

30,334

 

24,440

 

28,030

 

 

 

 

 

 

 

 

Equity and liabilities

 

 

 

 

 

 

 

Capital and reserves

 

 

 

 

 

 

 

Share capital

 

 

58

 

58

 

58

Merger reserve

 

 

14,595

 

14,595

 

14,595

Merger difference reserve

 

 

(13,147)

 

(13,147)

 

(13,147)

Translation reserve

 

 

32

 

(6)

 

(6)

Treasury reserve

 

 

(5)

 

(6)

 

(6)

Retained earnings

 

 

18,705

 

14,324

 

16,984

Equity attributable to owners of the Company

 

 

20,238

 

15,818

 

18,478

Total equity

 

 

20,238

 

15,818

 

18,478

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

Trade and other payables

 

 

8,745

 

7,463

 

8,406

Current tax liabilities

 

 

-

 

400

 

403

Derivative financial instruments

8

 

562

 

-

 

-

Total current liabilities

 

 

9,307

 

7,863

 

8,809

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

 

Deferred tax

 

 

789

 

759

 

743

Total liabilities

 

 

10,096

 

8,622

 

9,552

Total equity and liabilities

 

 

30,334

 

24,440

 

28,030

Condensed Consolidated Statements of Changes in Equity.

 

For the six months ended 29 February 2016

Share capital

Merger reserve

Merger difference reserve

Translation reserve

Treasury share reserve1

Share-based payment reserve

Retained earnings2

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 September 2015

58

14,595

(13,147)

(6)

(6)

262

16,722

18,478

Profit for the period

-

-

-

-

-

-

2,140

2,140

Other comprehensive income for the period

-

-

-

38

-

-

-

38

Total comprehensive income for the period

-

-

-

38

-

-

2,140

2,178

Transactions with owners of the Company:

 

 

 

 

 

 

 

 

Shares from EBT exercised

-

-

-

-

1

-

153

154

Share-based payments

-

-

-

-

-

60

-

60

Dividends paid

-

-

-

-

-

-

(632)

(632)

Balance at 29 February 2016

58

14,595

(13,147)

32

(5)

322

18,383

20,238

 

 

 

 

 

 

 

 

 

For the six months ended 28 February 2015

Share capital

Merger reserve

Merger difference reserve

Translation reserve

Treasury share reserve1

Share-based payment reserve

Retained earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 September 2014

52

-

1,448

(6)

-

140

11,574

13,208

Profit for the period

-

-

-

-

-

-

2,864

2,864

Other comprehensive income for the period

-

-

-

-

-

-

-

-

Total comprehensive income for the period

-

-

-

-

-

-

2,864

2,864

Transactions with owners of the Company:

 

 

 

 

 

 

 

 

Issue of ordinary shares

6

-

-

-

-

-

-

6

Ordinary shares issued to the EBT

-

-

-

-

(6)

-

-

(6)

Share for share exchange

-

14,595

(14,595)

-

-

-

-

-

Share-based payments

-

-

-

-

-

60

-

60

Dividends paid

-

-

-

-

-

-

(314)

(314)

Balance at 28 February 2015

58

14,595

(13,147)

(6)

(6)

200

14,124

15,818

                 

 

1The reserve for the Company's treasury shares comprises the cost of the Company's shares held by the Group. At 29 February 2016, the Employee Benefit Trust held 4,627,861 of the Company's shares (six months ended 28 February 2015: 5,676,000)

 

2Of the retained earnings totalling £18,383,032, £151,980 relates to the gain on exercise of share options from the EBT and is therefore non-distributable.

 

Condensed Consolidated Statements of Changes in Equity (Continued)

 

 

 

 

 

 

 

 

 

 

For the year ended 31 August 2015

Share capital

Merger reserve

Merger difference reserve

Translation reserve

Treasury share reserve

Share-based payment reserve

Retained earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at 1 September 2014

52

-

1,448

(6)

-

140

11,574

13,208

Profit for the period

-

-

-

-

-

-

5,462

5,462

Other comprehensive income for the period

-

-

-

-

-

-

-

-

Total comprehensive income for the period

-

-

-

-

-

-

5,462

5,462

Transactions with owners of the Company:

 

 

 

 

 

 

 

 

Issue of ordinary shares

6

-

-

-

-

-

-

6

Ordinary shares issued to the EBT

-

-

-

-

(6)

-

-

(6)

Share for share exchange

-

14,595

(14,595)

-

-

-

-

-

Share-based payments

-

-

-

-

-

122

-

122

Dividends paid

-

-

-

-

-

-

(314)

(314)

Balance at 31 August 2015

58

14,595

(13,147)

(6)

(6)

262

16,722

18,478

 

 

 

 

Consolidated Statement of Cash Flow

For the six months ended 29 February 2016

 

 

 

6 months to29 February 2016

6 months to28 February 2015

Year to31 August 2015

 

Note

£'000

£'000

£'000

Cash flows from operating activities

 

 

 

 

Profit for the period before non-underlying items

 

2,677

3,568

6,166

Non-underlying items

5

(537)

(704)

(704)

Profit for the period

 

2,140

2,864

5,462

Adjustments for:

 

 

 

 

Income tax expense

 

292

622

1,022

Net finance (income)/charge

 

723

(528)

(164)

(Profit)/loss on disposal of property, plant and equipment

 

-

-

(1)

Amortisation of intangibles

 

914

829

1,902

Depreciation of property, plant and equipment

 

215

186

368

Share-based payment charge

 

60

60

122

Operating cash flow before movements in working capital

 

4,344

4,033

8,711

(Increase) in trade and other receivables

 

(1,988)

(129)

(1,370)

(Increase) in inventories

 

(2,099)

(1,243)

(2,037)

Increase in trade and other payables

 

339

461

1,718

Operating cash flow before interest and tax paid

 

596

3,122

7,022

Cash outflow in respect of non-underlying items

 

90

1,086

1,186

Operating cash flow before non-underlying items, interest and tax paid

 

686

4,208

8,208

Net interest (paid)/received

 

(89)

3

6

Income tax paid

 

(732)

(459)

(838)

Cash generated by operations

 

(225)

2,666

6,190

Net foreign exchange movement

 

189

70

53

Net cash inflow/(outflow) from operating activities

 

(36)

2,736

6,243

Cash flows from investing activities

 

 

 

 

Purchases of property, plant and equipment

 

(308)

(459)

(782)

Purchases of intangible assets

 

(1,399)

(1,355)

(2,778)

Proceeds from disposal of intangible assets

 

-

-

1

Net cash used in investing activities

 

(1,707)

(1,814)

(3,559)

Cash flows from financing activities

 

 

 

 

Issue of equity shares

 

154

-

-

Equity dividends paid

 

(632)

-

(314)

Net cash used in financing activities

 

(478)

-

(314)

Net increase/(decrease) in cash and cash equivalents

(2,221)

922

2,370

Cash and cash equivalents at beginning of year

 

6,173

3,803

3,803

Cash and cash equivalents at end of year

 

3,952

4,725

6,173

 

 

 

 

 

 

Notes to the Condensed Consolidated Interim Financial Statements

 

1. Basis of preparation and significant accounting policies

Focusrite Plc (the 'Company') is a company incorporated in the United Kingdom. The condensed consolidated interim financial statements ('interim financial statements') as at and for the six months ended 29 February 2016 comprised the Company and its subsidiaries (together referred to as the 'Group').

 

The Group is a business engaged in the development, manufacture and marketing of professional audio and electronic music products.

 

Statement of compliance

The condensed interim consolidated financial statements ('the interim financial statements') are for the six months ended 29 February 2016 and are presented in pounds Sterling ('GBP'). This is the functional currency of the Group. The interim financial report has been prepared in accordance with the International Financial Reporting Standards ('IFRS'), International Accounting Standards ('IAS') and interpretations currently endorsed by the International Accounting Standards Board ('IASB') and its committees as adopted by the EU and as required to be adopted by AIM listed companies. AIM listed companies are not required to comply with IAS 34 'Interim Financial Reporting' and accordingly the Company has taken advantage of this exemption. They do not include all the information required for a complete set of IFRS financial statements. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group's financial position and performance since the last annual consolidated financial statements as at and for the year ended 31 August 2015.

 

These interim financial statements were authorised for issue by the Company's Board of Directors on 26 April 2016.

 

Significant accounting policies

The interim financial statements have been prepared in accordance with the accounting policies adopted in the Group's financial statements for the year ended 31 August 2015.

 

1.1 Basis of consolidation

The consolidated financial statements comprise the financial statements of the Company and subsidiaries controlled by the Company drawn up to 29 February 2016.

 

1.2 Subsidiaries

Subsidiaries are entities controlled by the Group. Control exists when the Group has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities. In assessing control, the Group takes into consideration potential voting rights that are currently exercisable. The acquisition date is the date on which control is transferred to the acquirer. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date control ceases.

 

1.3 Going concern

The Board of Directors have a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on a going concern basis.

 

1.4 Earnings per share

The Group presents basic and diluted earnings per share ('EPS') data for its ordinary shares. Basic EPS is calculated by dividing the profit attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. For diluted EPS, the weighted average number of ordinary shares is adjusted for the dilutive effect of potential ordinary shares arising from the exercise of granted share options.

For the period reported, the Group has chosen to present an adjusted EPS (Note 7) calculation with profit adjusted for non-underlying items to aid comparability and to provide a consistent measure of performance.

 

1.5 Non-underlying items

Non-underlying items are those items that are unusual because of their size, nature or incidence. The Directors consider that these items should be separately identified to ensure a full understanding of the Group's results.

 

1.6 Accounting estimates and judgements

In application of the Group's accounting policies, the Directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

In preparing these condensed consolidated interim financial statements, the significant judgements made by the Directors in applying the Group's accounting policies and key sources of estimation uncertainty were the same as those applied to the Group's financial statements for the year ended 31 August 2015.

 

1.7 Foreign currencies

Transactions in foreign currencies are translated to the functional currency of the Group at the foreign exchange rate at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the reporting date are translated to the functional currency at the period end date. Foreign exchange differences arising on the translation are recognised in the consolidated income statement. Non-monetary assets and liabilities that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of transactions.

The assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on consolidation, are translated to the Group's presentational currency, Sterling, at the period end foreign exchange rate ruling at the reporting date. The revenue and expenses of foreign operations are translated at an average rate for the period where this rate approximates to the foreign exchange rate ruling at the dates of the transaction.

 

Exchange differences arising from the translation of foreign operations are reported as an item of other comprehensive income and accumulated in the translation reserve.

 

2. Revenue

 

An analysis of the Group's revenue is as follows:

 

 

6 months to29 February 2016 (unaudited)

6 months to28 February 2015 (unaudited)

Year to31 August 2015 (audited)

£'000

£'000

£'000

Continuing operations

 

 

 

 

USA

 

9,069

8,476

18,498

Europe, Middle East and Africa

 

12,064

11,659

21,460

Rest of World

 

4,747

3,663

8,071

Consolidated revenue

 

25,880

23,798

48,029

 

3. Operating segments

 

Products and services from which reportable segments derive their revenues

 

Information reported to the Group's Chief Executive (who has been determined to be the Group's Chief Operating Decision Maker) for the purposes of resource allocation and assessment of segment performance is focused on the main product groups which the Group sells. The Group's reportable segments under IFRS 8 are therefore as follows:

Focusrite - Sales of Focusrite branded products

Novation - Sales of Novation branded products

Distribution - Distribution of third party brands including KRK speakers, Stanton, Cerwin Vega, Cakewalk, sE Electronics

 

3. Operating segments (Continued)

The revenue and profit generated by each of the Group's operating segments are summarised as follows:

 

6 months to29 February 2016

6 months to28 February 2015

Year to31 August 2015

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Revenue from external customers

 

 

 

Focusrite

16,946

15,330

31,187

Novation

7,287

6,831

14,169

Distribution

1,647

1,637

2,673

Total

25,880

23,798

48,029

Segment profit

 

 

 

Focusrite

7,986

7,090

14,221

Novation

3,670

3,519

6,842

Distribution

557

528

846

 

12,213

11,137

21,909

Central distribution costs and administrative expenses

(8,521)

(7,475)

(14,885)

Adjusted operating profit before non-underlying items

3,692

3,662

7,024

Non-underlying items

(537)

(704)

(704)

Operating profit

3,155

2,958

6,320

Finance income

2

528

164

Finance costs

(725)

-

-

Profit before tax

2,432

3,486

6,484

Tax

(292)

(622)

(1,022)

Profit after tax

2,140

2,864

5,462

 

Segment profit represents the profit earned by each segment without allocation of the share of central administration costs including Directors' salaries, finance income and finance costs, and income tax expense. This is the measure reported to the Group's Chief Executive for the purpose of resource allocation and assessment of segment performance.

Central administration costs comprise principally the employment related costs and other overheads incurred by the Group. Also included within central administration costs is the charge relating to the share option scheme of £60,000 for the six-month period to 29 February 2016 (six months to 28 February 2015: £60,000; year to 31 August 2015: £122,200).

 

3. Operating segments (continued)

Segment net assets and other segment information

Management does not make use of segmental data relating to net assets and other balance sheet information for the purposes of monitoring segment performance and allocating resources between segments. Accordingly, other than the analysis of the Group's non-current assets by region shown below, this information is not available for disclosure in the consolidated financial information.

 

The Group's non-current assets, analysed by region, were as follows:

 

 

29 February 2016

28 February 2015

31 August 2015

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Non-current assets

 

 

 

USA

26

25

29

Europe, Middle East and Africa

5,141

4,353

4,683

Rest of World

674

417

552

Total non-current assets

5,841

4,795

5,264

 

 

 

4. Taxation

 

The tax charge for the six months to 29 February 2016 is based on the estimated tax rate for the full year in each jurisdiction

 

5. Non-underlying items

During the six months to 29 February 2016, the Group incurred one-off litigation costs relating to intellectual property and distribution contracts, totalling £0.5 million, which were charged to the income statement. In December 2014, the Group floated on the London Stock Exchange AIM market. Non-recurring IPO related costs totalled £0.7 million, which were charged to the income statement for the period to 28 February 2015 and year ended 31 August 2015.

 

6. Dividends

 

The following equity dividends have been declared:

 

6 months to29 February 2016 (unaudited)

6 months to28 February 2015 (unaudited)

Year to31 August 2015 (audited)

Dividend per qualifying ordinary share

 0.65p

 0.6p

 1.8p

 

 

During the period, the Company paid a final dividend in respect of the year ended 31 August 2015 of 1.2 pence per share, amounting to £631,170.

 

7. Earnings per share

 

Reported earnings per share

The calculation of the basic and diluted earnings per share is based on the following data:

Earnings

6 months to29 February

2016

(unaudited)

6 months to28 February 2015

(unaudited)

Year to31 August

2015

(audited)

 

£'000

£'000

£'000

Earnings for the purposes of basic and diluted earnings per share being net profit for the period

2,140

2,864

5,462

Earnings for the purposes of diluted earnings per share

2,140

2,864

5,462

 

 

 

 

 

6 months to29 February

2016

6 months to28 February 2015

Year to31 August

2015

 

number

number

number

 

'000

'000

'000

 

 

 

 

Number of shares

 

 

 

Weighted average number of ordinary shares for the purposes of basic earnings per share calculation

52,877

52,399

52,399

Effect of dilutive potential ordinary shares:

 

 

 

EMI share option scheme and unapproved share option plan

5,696

7,382

6,416

Weighted average number of ordinary shares for the purposes of diluted earnings per share calculation

58,573

59,781

58,815

 

 

 

 

Earnings per share

Pence

Pence

Pence

Basic earnings per share

4.0

5.5

10.4

Diluted earnings per share

3.7

4.8

9.3

 

7. Earnings per share (continued)

At 29 February 2016, the total number of ordinary shares issued and fully paid was 58,075,000. This included 4,627,861 shares held by the Employee Benefit Trust ('EBT') to satisfy options vesting in future years. The operation of this Employee Benefit Trust is funded by the Group so the EBT is required to be consolidated, with the result that the weighted average number of ordinary shares for the purpose of the basic earnings per share calculation is the net of the total number of shares in issue (58,075,000) less the weighted average number of shares held by the Employee Benefit Trust (5,098,003). It should be noted that the only right relinquished by the Trustees of the Employee Benefit Trust is the right to receive dividends. In all other respects, the shares held by the Employee Benefit Trust have full voting rights.

The effect of dilutive potential ordinary share issues is calculated in accordance with IAS 33 and arises from the employee share options currently outstanding, adjusted by the profit element as a proportion of the average share price during the period.

 

Adjusted earnings per share

 

Earnings

6 months to29 February

2016

(unaudited)

6 months to28 February 2015

(unaudited)

Year to31 August

2015

(audited)

 

£'000

£'000

£'000

Profit for the financial period

2,140

2,864

5,462

Non-underlying items

537

704

704

Total underlying profit for adjusted earnings per share calculation

2,677

3,568

6,166

 

 

 

 

 

6 months to29 February

2016

6 months to28 February 2015

Year to31 August

2015

 

number

number

number

 

'000

'000

'000

Number of shares

 

 

 

Weighted average number of ordinary shares for the purposes of basic earnings per share calculation

52,877

52,399

52,399

Effect of dilutive potential ordinary shares:

 

 

 

EMI share option scheme and unapproved share option plan

5,696

7,382

6,416

Weighted average number of ordinary shares for the purposes of diluted earnings per share calculation

58,573

59,781

58,815

 

 

 

 

Earnings per share

Pence

Pence

Pence

Adjusted basic earnings per share

5.1

6.8

11.8

Adjusted diluted earnings per share

4.6

6.0

10.5

 

 

8. Financial instruments

 

The fair value of the Group's derivative financial instruments is calculated using the quoted prices. Where such prices are not available, a discounted cash flow analysis is performed using applicable yield curve for the duration of the instruments for non-optional derivatives, and option pricing model for optional derivatives. Foreign currency forward contracts are measured using quoted forward exchange rates and yield curves derived from quoted interest rates matching maturities of the contract.

 

IFRS13 Fair value measurements requires the Group's derivative financial instruments to be disclosed at fair value and categorised in three levels according to the inputs used in the calculation of their fair value.

 

Financial instruments carried at fair value should be measured with reference to the following levels:

· Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;

· Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or

liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and

· Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The financial instruments held by the Group that are measured at fair value all related to financial assets/ (liabilities) measured at fair value through profit and loss ('FVTPL') using a Level 2 valuation method.

 

The fair value of financial assets and liabilities held by the Group are:

 

 

 

29 February 2016

28 February 2015

31 August 2015

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Financial assets

 

 

 

Cash and cash equivalents

3,952

4,725

6,173

Forward exchange contracts

-

585

223

Trade receivables

7,306

5,295

6,464

 

11,258

10,605

12,860

Financial liabilities

 

 

 

Fair value through profit and loss (FVTPL)

 

 

 

Forward exchange contracts

562

-

-

Amortised cost

 

 

 

Trade payables

5,307

3,995

5,197

 

5,869

3,995

5,197

 

 

 

 

Independent Review Report to Focusrite Plc

Introduction

We have been engaged by the company to review the condensed set of financial statements in the half-yearly report for the six months ended 29 February 2016 which comprises the condensed consolidated state of profit and loss and other comprehensive income, condensed consolidated statement of financial position, condensed consolidated statement of changes in equity, condensed consolidated statement of cash flow and the related explanatory notes. We have read the other information contained in the half-yearly report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

This report is made solely to the company in accordance with the terms of our engagement. Our review has been undertaken so that we might state to the company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our review work, for this report, or for the conclusions we have reached. Directors' responsibilities

The half-yearly report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly report in accordance with the AIM Rules.

As disclosed in note 1, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the EU. The condensed set of financial statements included in this half-yearly report has been prepared in accordance with the recognition and measurement requirements of IFRSs as adopted by the EU. 

Our responsibility

Our responsibility is to express to the company a conclusion on the condensed set of financial statements in the half-yearly report based on our review.

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly report for the six months ended 29 February 2016 is not prepared, in all material respects, in accordance with the recognition and measurement requirements of IFRSs as adopted by the EU and the AIM Rules.

 

Peter Meehan (Senior Statutory Auditor)

for and on behalf of KPMG LLP

Chartered Accountants

One Snowhill

Snow Hill Queensway

Birmingham

B4 6GH

26 April 2016

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR IAMFTMBATBMF
Date   Source Headline
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions
18th Mar 20247:00 amRNSTrading Update
14th Feb 20243:10 pmRNSNotification of PDMR Transactions
7th Feb 20242:25 pmRNSTR-1
19th Jan 202412:59 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement
8th Jan 20244:36 pmRNSTR-1
2nd Jan 20247:00 amRNSPHIL DUDDERIDGE AWARDED OBE
19th Dec 20237:00 amRNSAcquisition of Sheriff Technology Limited
7th Dec 20233:58 pmRNSTR-1
5th Dec 20232:02 pmRNSGrant of Share Options to PDMRs
5th Dec 20231:54 pmRNSDirector Share Dealings
29th Nov 20234:51 pmRNSTR-1
28th Nov 20237:00 amRNSFinal Results
17th Nov 202310:27 amRNSTR-1
17th Nov 20237:00 amRNSTR-1
7th Nov 20237:00 amRNSTR-1
31st Oct 20237:00 amRNSNotice of Final Results
14th Sep 20237:00 amRNSTrading Update for the year ended 31 August 2023
9th Jun 202310:54 amRNSNotification of PDMR Transactions
16th May 20237:20 amRNSChange of Registered Office
3rd May 20237:00 amRNSPDMR Dealings
26th Apr 20232:39 pmRNSInterim Dividend Timetable Correction
25th Apr 20237:00 amRNSHalf year results
11th Apr 20231:28 pmRNSNotice of Interim Results
14th Mar 20237:00 amRNSTrading Update
22nd Feb 20239:25 amRNSNotification of PDMR Transactions
7th Feb 20239:51 amRNSPDMR Dealings
3rd Feb 202312:49 pmRNSResult of AGM
3rd Feb 20237:00 amRNSAGM Statement and Update on Trading
18th Jan 20237:00 amRNSSettlement of Share Options
18th Jan 20237:00 amRNSNotification of PDMR Transaction
16th Jan 202311:43 amRNSSettlement of Share Options
22nd Dec 202211:49 amRNSGrant of Share Options to PDMRs
20th Dec 20227:00 amRNSAcquisition of Sonnox Limited
14th Dec 20227:00 amRNSPDMR
8th Dec 20229:05 amRNSSecond Price Monitoring Extn
8th Dec 20229:00 amRNSPrice Monitoring Extension
8th Dec 20227:00 amRNSFinal Results
7th Dec 202211:12 amRNSShare issuance to Employee Benefit Trust
21st Nov 20227:00 amRNSChange to Final Results announcement date
7th Nov 20227:00 amRNSNotice of Final Results
27th Oct 20221:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.